The causative agent of a recent outbreak of an atypical pneumonia, known as severe acute respiratory syndrome (SARS), has been identified as a coronavirus (CoV) not belonging to any of the previously identified groups. Fusion of coronaviruses with the host cell is mediated by the envelope spike protein. Two regions within the spike protein of SARS-CoV have been identified, showing a high degree of sequence conservation with the other CoV, which are characterized by the presence of heptad repeats (HR1 and HR2). By using synthetic and recombinant peptides corresponding to the HR1 and HR2 regions, we were able to characterize the fusionactive complex formed by this novel CoV by CD, native PAGE, proteolysis protection analysis, and size-exclusion chromatography. HR1 and HR2 of SARS-CoV associate into an antiparallel six-helix bundle, with structural features typical of the other known class I fusion proteins. We have also mapped the specific boundaries of the region, within the longer HR1 domain, making contact with the shorter HR2 domain. Notably, the inner HR1 coiled coil is a stable ␣-helical domain even in the absence of interaction with the HR2 region. Inhibitors binding to HR regions of fusion proteins have been shown to be efficacious against many viruses, notably HIV. Our results may help in the design of anti-SARS therapeutics.T he causative agent of the outbreak of the atypical pneumonia known as severe acute respiratory syndrome (SARS) (1) has been identified as a coronavirus (CoV) (2-9). Phylogenetic analysis of the SARS-associated CoV (SARS-CoV) shows that it is neither a mutant nor a recombinant of previously characterized CoV (10, 11), and forms a new, distinct group within the genus (3,4,8,9).The fusogenic envelope glycoprotein of CoV, the spike protein (S protein), which is displayed in Ϸ200 copies on the viral membrane as a trimer (12, 13), is divided into two subdomains of similar size: S1 and S2, which have distinct functions (11). S1, which forms the globular portion of the spike, mediates binding to host cell receptors (11,(14)(15)(16). For SARS-CoV, the receptor-binding domain is localized to amino acids 318-510 (15, 16), which bind angiotensin-converting enzyme 2 (15, 17). S2, which is more conserved (9, 11), forms the membrane-anchored stalk region (18) and mediates viral-host cell fusion (13,(19)(20)(21). Cleavage between S1͞S2 is not an absolute requirement for the fusion of CoV (4,11,17,[21][22][23][24], and the available data suggest that the S protein of SARS-CoV is not cleaved into subunits (4, 9, 17).The SARS-CoV S protein shares little amino acid similarity with other CoV (9). However, S2 contains two predicted amphipathic ␣-helical regions, with a 4,3 heptad repeat (HR), characteristic of coiled coils (9). The position and sequence of these HR regions are conserved among all groups of coronaviruses (18), including .HR regions are a common feature of Type I viral fusion proteins (26-40). These usually feature an N-terminal HR (HR1) adjacent to the fusion peptide, and a C-terminal HR ...